Oral Toxicities With Antibody-Drug Conjugates: What Physicians Should Know - Poll - DentalSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Oral Toxicities With Antibody-Drug Conjugates: What Physicians Should Know

Antibody-drug conjugates (ADCs) have become an increasingly important part of treatment for several advanced cancers, pairing a tumor-targeting antibody with a cytotoxic payload.

  • By

  • October 9, 2026

  • 4 min

Share

Original Source(s)

Oral Toxicities With Antibody-Drug Conjugates: What Physicians Should Know

  • by

  • October 9, 2026

Related Content

Error in Supplement 2

  • October 19, 2026

Musings From the Power List: Jason Bock

Jason Bock shares his outlook on RNA-targeting therapies, personalized medicine, and the future of drug development

Construction of an AI-Assisted Pedigree Mapping System for Hereditary Gynecological Tumors: Algorithm Development and Pilot Validation Study